Companies: 10,795·Total market cap: $144.5T
Neogen Corporation

Neogen Corporation

NEOGNASDAQHealthcare● Active
$9.09
+$0.19(+2.08%)
Market Cap$2.0B
P/E Ratio
52W High$11.43
52W Low$4.56
SEC Filings

Neogen Corporation (NEOG) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000711377 · NEOG · NASDAQ · as of Jun 8, 2026

Filing snapshot

1,000+
Total Filings
4
Latest Form
2026-06-04
Most Recent
1989
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0000711377 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-07-30
Fiscal Year End
Jul 30, 2025
Accession No.
0000950170-25-100064
Primary Document
neog-20250531.htm
Source: data.sec.gov · CIK 0000711377 · Accession 0000950170-25-100064

Latest Key Filings

10-QQuarterly Report
10-Q
2026-04-09
8-KCurrent Report
8-K
2026-04-20Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SDSD
SD
2026-05-20
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-30
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-04-29
View
8-KCurrent Report
8-K
2026-04-20
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-04-13
View
10-QQuarterly Report
10-Q
2026-04-09
View
8-KCurrent Report
8-K
2026-04-09
View
8-KCurrent Report
8-K
2026-03-30
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-27
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-01-26
View
10-QQuarterly Report
10-Q
2026-01-08
View
8-KCurrent Report
8-K
2026-01-08
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-12-04
View
Showing 1–15 of 390 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000711377  |  Exchange: NASDAQ · Healthcare

Neogen Corporation (NASDAQ: NEOG) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1989. As a Healthcare sector company with CIK 0000711377, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Neogen Corporation's most comprehensive regulatory disclosure. The most recent Neogen Corporation 10-K was filed on 2025-07-30 for fiscal year ending 2025. Historical NEOG 10-K annual reports are available from 2013 through 2025.

Investors researching Neogen Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

NEOG SEC Filings · 8 questions

Neogen Corporation (NEOG) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. Neogen Corporation's CIK is 0000711377.

NEOG SEC filingsNeogen Corporation SEC documentsfind NEOG 10-K